TAILIEUCHUNG - Overview of the Urological and Gynecological Devices Market

Our list of providers was determined from the HHSC’s list of providers who billed the WHP in state fiscal year 2011. In each county, Planned Parenthood centers saw the largest number of WHP patients, based on statistics for state fiscal year 2011, as shown in Table 4. 44 Planned Parenthood affiliates often operate multiple clinics or sites, particularly in the larger urban areas. In this report, we use the term “affiliate” to refer to a Planned Parenthood organization, which may have multiple clinics or sites. The WHP provider list is based on the billing address. | Overview of the Urological and Gynecological Devices Market January 2009 Brocair Partners Industry Survey Series Brocair Partners LLC I 317 Madison Avenue 21st Floor I New York NY 10017 I I BRQCA1R i ARTNIiRS Intelligent Healthcare Investment Banking Table of Contents 1. Select Participants in the Urological Devices Market 3 2. Select Participants in the Gynecological Devices Market 4 3. Profiles of Select Participants in Urological and Gynecological Devices Market 5 4. Comparable Companies Analysis - Urological and Gynecological Devices Market 14 5. Comparable Credit Analysis - Urological and Gynecological Devices Market 15 6. Recent Transactions - Urological and Gynecological Devices Market 16 7. Indexed Stock Price Performance 24 8. Disclaimer 25 9. Contact Information 26 Disclaimer This report has been exclusively prepared by Brocair Partners LLC Brocair Partners . This document should not be in any way construed as providing investment advice or investment services. This report does not constitute an offer or invitation to purchase assets or securities of any kind in the companies described herein. This report is being furnished to you for informational purposes only and on the condition that it will not form the basis for any investment decision. Brocair Partners makes no recommendation whatsoever of the merits of any investment in any company listed in this report. Brocair Partners does not provide any warranty or make any representation of the correctness or the completeness of any information provided. Please see page 25 for full disclaimer. BRQCA1R i ARTNIiRS Intelligent Healthcare Investment Banking Section 1 I Select Participants in the Urological Devices Market 1. Select Participants in the Urological Devices Market Urological conditions include kidney stone disease urolithiasis incontinence in men and women benign prostate hyperplasia BPH noncancerous swelling of prostate occurring in men with increasing age prostate .

• Sức khỏe phụ nữ
• Melanoma Skin Cancer
• Reconstructed Skin
• Analyze Stratum corneum
• Remodeling
• Epidermal Modifications
• Keratinocyte Culture Techniques
• BMC Cancer
• Diabetes mellitus
• Non melanoma skin cancer
• Sensitivity analyses
• Cox regression
• Melanoma morbidity
• Skin cancer
• Melanoma surgical treatment
• Melanoma quality improvement
• Skin self examination
• Melanoma early detection
• Melanoma patients
• Observational study
• Basal cell carcinoma
• P53 gene family
• Epithelial tissue growth
• Breast cancer cells
• Molecular genetics
• Gene expression
• Single nucleotide polymorphism
• Transcription factor
• Grainyhead like
• Risk factor
• Malignant melanoma
• Lentigo maligna
• Primary care
• Randomised Controlled Trial
• Self directed care
• Melanoma incidence
• Non coding RNAs
• Including melanoma
• Testis expressed 41
• Immune infiltrates
• SKCM metastasis
• Skin cutaneous melanoma
• Cancers worldwide
• Gene Expression Profiling Interactive Analysis
• Human skin cutaneous melanoma
• Competitive endogenous RNA
• Potential therapeutic
• Cox regression model
• Cutaneous melanoma
• Cutaneous squamous cell carcinoma
• Bowen’s disease
• Actinic keratosis
• Cutaneous malignant melanoma
• Melanoma risk
• Candidate gene
• Genome wide association studies
• Skin phototypes
• Boolean networks
• Metastatic melanoma
• Anti cancer treatments including surgery
• Chemo therapy
• Human melanoma cells
• Aglaia foveolata
• Silvestrol triggers autophagy
• Human cancer cells
• Solid tumors
• Burden of disease
• Years lived with disability
• Public health policies
• Prohibitin 1
• Melanoma cell death
• Tumor suppressor molecule
• TNM staging
• Survival analysis
• Skin cancer screening
• Stage distribution
• Despite recent advances
• Nifuroxazide analogues
• Pharmacophore similarity
• Intrinsic activity
• Breast cancer
• Metastatic cancer
• Reduce ethnic
• Multivariate models adjusting
• Serum Markers
• Clinical Management
• Suncare Products
• Clinical Aspects
• Non melanoma skin cancers
• People with albinism
• Melanin increase
• Histological types
• Several cancers
• Chronic Kidney Disease
• Cardiac Catheterization
• Cardiomyopathy